45 related articles for article (PubMed ID: 19203467)
21. The amine oxidase inhibitor phenelzine limits lipogenesis in adipocytes without inhibiting insulin action on glucose uptake.
Carpéné C; Grès S; Rascalou S
J Neural Transm (Vienna); 2013 Jun; 120(6):997-1003. PubMed ID: 23242743
[TBL] [Abstract][Full Text] [Related]
22. GABA-elevating effects of the antidepressant/antipanic drug phenelzine in brain: effects of pretreatment with tranylcypromine, (-)-deprenyl and clorgyline.
Todd KG; Baker GB
J Affect Disord; 1995 Dec; 35(3):125-9. PubMed ID: 8749840
[TBL] [Abstract][Full Text] [Related]
23. Phenelzine causes an increase in brain ornithine that is prevented by prior monoamine oxidase inhibition.
MacKenzie EM; Grant SL; Baker GB; Wood PL
Neurochem Res; 2008 Mar; 33(3):430-6. PubMed ID: 17768678
[TBL] [Abstract][Full Text] [Related]
24. Effects of the MAO inhibitor phenelzine on glutamine and GABA concentrations in rat brain.
Paslawski TM; Sloley BD; Baker GB
Prog Brain Res; 1995; 106():181-6. PubMed ID: 8584653
[TBL] [Abstract][Full Text] [Related]
25. Effects of the antidepressant/antipanic drug phenelzine on alanine and alanine transaminase in rat brain.
Tanay VA; Parent MB; Wong JT; Paslawski T; Martin IL; Baker GB
Cell Mol Neurobiol; 2001 Aug; 21(4):325-39. PubMed ID: 11775064
[TBL] [Abstract][Full Text] [Related]
26. Time-dependent changes in brain monoamine oxidase activity and in brain levels of monoamines and amino acids following acute administration of the antidepressant/antipanic drug phenelzine.
Parent MB; Habib MK; Baker GB
Biochem Pharmacol; 2000 May; 59(10):1253-63. PubMed ID: 10736426
[TBL] [Abstract][Full Text] [Related]
27. Neurochemical effects of the monoamine oxidase inhibitor phenelzine on brain GABA and alanine: A comparison with vigabatrin.
Todd KG; Baker GB
J Pharm Pharm Sci; 2008 May; 11(2):14s-21s. PubMed ID: 19203467
[TBL] [Abstract][Full Text] [Related]
28. Overview of the Neuroprotective Effects of the MAO-Inhibiting Antidepressant Phenelzine.
Matveychuk D; MacKenzie EM; Kumpula D; Song MS; Holt A; Kar S; Todd KG; Wood PL; Baker GB
Cell Mol Neurobiol; 2022 Jan; 42(1):225-242. PubMed ID: 33839994
[TBL] [Abstract][Full Text] [Related]
29. Attenuation of the effects of oxidative stress by the MAO-inhibiting antidepressant and carbonyl scavenger phenelzine.
Baker G; Matveychuk D; MacKenzie EM; Holt A; Wang Y; Kar S
Chem Biol Interact; 2019 May; 304():139-147. PubMed ID: 30857888
[TBL] [Abstract][Full Text] [Related]
30. Insights into the mechanisms of action of the MAO inhibitors phenelzine and tranylcypromine: a review.
Baker GB; Coutts RT; McKenna KF; Sherry-McKenna RL
J Psychiatry Neurosci; 1992 Nov; 17(5):206-14. PubMed ID: 1362653
[TBL] [Abstract][Full Text] [Related]
31. An update on amine oxidase inhibitors: multifaceted drugs.
Song MS; Matveychuk D; MacKenzie EM; Duchcherer M; Mousseau DD; Baker GB
Prog Neuropsychopharmacol Biol Psychiatry; 2013 Jul; 44():118-24. PubMed ID: 23410524
[TBL] [Abstract][Full Text] [Related]
32. Metabolism of monoamine oxidase inhibitors.
Baker GB; Urichuk LJ; McKenna KF; Kennedy SH
Cell Mol Neurobiol; 1999 Jun; 19(3):411-26. PubMed ID: 10319194
[TBL] [Abstract][Full Text] [Related]
33.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
34.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
35.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
36.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
